The phototherapy treatment market is projected to be valued at US$ 1,948.90 million in 2023. The market research report anticipates a valuation of US$ 3,230.90 million by 2033. The phototherapy treatment market is expected to record a CAGR of 5.20% during the forecast period.
Phototherapy Treatment Market Trends and Highlights
| Attributes | Key Insights |
|---|---|
| Market Estimated Size in 2023 | US$ 1,948.90 million |
| Projected Market Value in 2033 | US$ 3,230.90 million |
| Value-based CAGR from 2023 to 2033 | 5.20% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Skin diseases are among the most common of all human health afflictions and affect almost 900 million people in the world at any time. Five common conditions account for over 80% of all skin diseases. These may cause rashes, inflammation, itchiness, or other skin changes. Some skin conditions may be genetic, while lifestyle factors may cause others. Skin disease treatment may include medications, creams, ointments, or lifestyle changes.
Phototherapy has emerged as a highly effective approach to addressing many skin problems in recent years. Phototherapy uses light waves to treat certain skin conditions. The skin is exposed to ultraviolet (UV) light for a set amount of time. Phototherapy uses a man-made source of UV light. UV light also comes from the sun. When combined with a medication called psoralen, the procedure is known as psoralen UVA (PUVA).
UV light shuts down immune system cells in the skin. It can help in skin conditions caused by an immune system overreaction. Some conditions that can be cured using this approach include psoriasis, eczema, mycosis fungoides, and vitiligo, among others. As awareness of phototherapy's benefits in treating acne grows among patients and healthcare providers, more individuals are seeking this form of treatment.
| Market Value in 2022 | 1,838.10 million |
|---|---|
| Market Value in 2033 | 3,230.90 million |
Principal Consultant
In addition to the phototherapy treatment market, this report also discusses the key attributes of two adjacent markets: the hypercalcemia treatment market and the hypogonadism treatment market. Tables below highlight the growth rates, key trends, and opportunities of all three markets, providing a comprehensive analysis of their performance over the forecast period.
Phototherapy Treatment Market:
| CAGR from 2023 to 2033 | 5.20% |
|---|---|
| Market Value in 2023 | US$ 3,230.90 million |
| Future Opportunities |
|
| Growth Factor |
|
| Market Trends |
|
Hypercalcemia Treatment Market:
| CAGR from 2023 to 2033 | 11.8% |
|---|---|
| Market Value in 2023 | US$ 18.07 billion |
| Future Opportunities |
|
| Growth Factor |
|
| Market Trends |
|
Hypogonadism Treatment Market:
| CAGR from 2022 to 2032 | 5% |
|---|---|
| Market Value in 2022 | US$ 3.62 billion |
| Future Opportunities |
|
| Growth Factor |
|
| Market Trends |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| The United States | 2.30% |
|---|---|
| Germany | 3.10% |
| India | 7.80% |
| China | 6.70% |
The phototherapy treatment market in the United States has been steadily growing, driven by factors such as the increasing prevalence of skin disorders like psoriasis and eczema. The market has benefited from advancements in technology and a growing acceptance of phototherapy as an effective treatment option
The phototherapy market in the United States is well-developed and advanced, with a high prevalence of skin disorders. Technological advancements and a strong regulatory framework contribute to market growth. Accessibility to phototherapy services is relatively good, particularly in urban areas.
The growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment. The population of adult women is rising at higher rates in the United States. United States is to account for a CAGR of 2.30% by the end of 2023
Germany is a major player in the European phototherapy market. The country has a strong focus on healthcare technology and innovation, leading to advancements in phototherapy equipment. High healthcare standards and insurance coverage support the market. Germany is to account for a CAGR of 3.10% by the end of 2023
The market benefits from ongoing research and development in dermatology and a well-regulated healthcare system with access to phototherapy treatments for various skin disorders. The presence of a substantial aging population contributes to the demand for dermatological treatments.
China is to account for a CAGR of 6.70% by the end of 2023. The phototherapy treatment market in China has been growing rapidly alongside the expansion of healthcare infrastructure. A large population and increasing awareness of dermatological treatments drive the market. The country's emerging middle class seeks access to advanced healthcare services. The market benefits from a strong emphasis on cosmetic dermatology and skin conditions.
Rising awareness of modern phototherapy, high per-capita disposable income, and the expansion of healthcare infrastructure is boosting phototherapy treatment in China. Growth in the percentage of newborns in China, an increase in the prevalence of neonatal jaundice, and the necessity for cost-effective treatment are all expected to fuel the market growth in China.
India is likely to closely follow China in the adoption of phototherapy treatment owing to its huge population base in the country. Regulatory reforms, favorable government policies, and improved healthcare infrastructure are expected to influence present and future market trends positively. India is to account for a CAGR of 7.80% by the end of 2023
The phototherapy market in India is growing due to the rising prevalence of skin disorders and increased healthcare spending. Phototherapy is available in major cities and urban centers, and the market is expanding to smaller towns and rural areas.
| Category | Market Share |
|---|---|
| Blue Light Therapy | 42.20% |
| Acne | 60.40% |
By phototherapy type, blue light therapy dominated the phototherapy treatment market for psoriasis and acne and is expected to be the most lucrative segment over the forecast period, with a market share of 42.20%.
Blue light therapy has been found to be effective in treating specific skin conditions, such as acne and actinic keratosis. It's particularly beneficial for those who have not responded well to other treatments. Blue light therapy can reduce the number of acne lesions and improve the appearance of the skin. Blue light therapy is a non-invasive and pain-free treatment. Patients do not experience discomfort during the procedure, making it more attractive, especially to those who are sensitive to pain or prefer non-surgical options.
Blue light therapy typically has minimal side effects. Patients may experience mild redness or temporary skin dryness, but these side effects are generally well-tolerated and short-lived.
The acne segment is expected to be the largest contributor to the market based on disease type. The acne segment is expected to account for a 60.4% share of the phototherapy treatment market in 2023.
Acne is one of the most common skin conditions globally, affecting a significant portion of the population, particularly adolescents and young adults. This widespread prevalence ensures a continuous demand for effective acne treatments.
Phototherapy, including blue light therapy and red light therapy, has demonstrated its efficacy in treating acne. These treatments can reduce the number of acne lesions, minimize inflammation, and improve the skin's overall appearance.
Companies indulged in developing phototherapy treatment therapies are actively seeking to strengthen their position through approval and agreements with established healthcare institutes. Collaborations, mergers & acquisition partnerships with regional players can accelerate their strategy to capture a significant share of the emerging markets.
Some of the developments by players in the phototherapy treatment market are given below-
| Attributes | Details |
|---|---|
| Estimated Market Size in 2023 | US$ 1,948.90 million |
| Projected Market Valuation in 2033 | US$ 3,230.90 million |
| Value-based CAGR 2023 to 2033 | 5.20% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in US$ million |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The phototherapy treatment market is expected to reach US$1,948.90 million in 2023.
The phototherapy treatment market is set to expand by a CAGR of 5.20% by 2033.
The phototherapy treatment market is forecast to reach US$ 3,230.90 million by 2033.
A significant share of profits will likely come from the Industry in North America.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Disease Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type, 2023 to 2033 5.3.1. Psoriasis 5.3.1.1. Guttate Psoriasis 5.3.1.2. Inverse Psoriasis 5.3.1.3. Pustular Psoriasis 5.3.1.4. Erythrodermic Psoriasis 5.3.1.5. Plaque Psoriasis 5.3.2. Acne 5.3.2.1. Acne Vulgaris 5.3.2.2. Acne Conglobate 5.3.2.3. Acne Fulminans 5.3.2.4. Gram-Negative Folliculitis 5.3.2.5. Acne Rosacea 5.3.2.6. Pyoderma Faciale 5.4. Y-o-Y Growth Trend Analysis By Disease Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Disease Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Phototherapy Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Phototherapy Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Phototherapy Type, 2023 to 2033 6.3.1. Blue Light Phototherapy 6.3.2. Red Light Phototherapy 6.3.3. Intense Pulsed Light (IPL) Phototherapy 6.3.4. Narrowband UVB Phototherapy 6.3.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy 6.4. Y-o-Y Growth Trend Analysis By Phototherapy Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Phototherapy Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Hospitals 7.3.2. Dermatology Clinics/Skin Care Centres 7.3.3. Wellness Centres 7.3.4. Home Care Settings 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Disease Type 9.2.3. By Phototherapy Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Disease Type 9.3.3. By Phototherapy Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Disease Type 10.2.3. By Phototherapy Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Disease Type 10.3.3. By Phototherapy Type 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Disease Type 11.2.3. By Phototherapy Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Disease Type 11.3.3. By Phototherapy Type 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Disease Type 12.2.3. By Phototherapy Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Disease Type 12.3.3. By Phototherapy Type 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Disease Type 13.2.3. By Phototherapy Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Disease Type 13.3.3. By Phototherapy Type 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Disease Type 14.2.3. By Phototherapy Type 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Disease Type 14.3.3. By Phototherapy Type 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Disease Type 15.2.3. By Phototherapy Type 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Disease Type 15.3.3. By Phototherapy Type 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Disease Type 16.1.2.2. By Phototherapy Type 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Disease Type 16.2.2.2. By Phototherapy Type 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Disease Type 16.3.2.2. By Phototherapy Type 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Disease Type 16.4.2.2. By Phototherapy Type 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Disease Type 16.5.2.2. By Phototherapy Type 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Disease Type 16.6.2.2. By Phototherapy Type 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Disease Type 16.7.2.2. By Phototherapy Type 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Disease Type 16.8.2.2. By Phototherapy Type 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Disease Type 16.9.2.2. By Phototherapy Type 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Disease Type 16.10.2.2. By Phototherapy Type 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Disease Type 16.11.2.2. By Phototherapy Type 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Disease Type 16.12.2.2. By Phototherapy Type 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Disease Type 16.13.2.2. By Phototherapy Type 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Disease Type 16.14.2.2. By Phototherapy Type 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Disease Type 16.15.2.2. By Phototherapy Type 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Disease Type 16.16.2.2. By Phototherapy Type 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Disease Type 16.17.2.2. By Phototherapy Type 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Disease Type 16.18.2.2. By Phototherapy Type 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Disease Type 16.19.2.2. By Phototherapy Type 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Disease Type 16.20.2.2. By Phototherapy Type 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Disease Type 16.21.2.2. By Phototherapy Type 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Disease Type 16.22.2.2. By Phototherapy Type 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Disease Type 16.23.2.2. By Phototherapy Type 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Disease Type 17.3.3. By Phototherapy Type 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Lifespan 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. UC Irvine Health 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Buffalo Medical Group 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Blackrock Clinic Limited 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. The Private Phototherapy Clinic Ltd 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. National Skin Centre 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Massachusetts General Hospital 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Signify Holding 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. GE Healthcare 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Natus Medical Incorporated 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Phototherapy Treatment Market
